Rubix LS
Delivering precision insight to create precision therapeutics with inclusive patient data
Connecting and powering the world's healthcare data through diversity patient analytics
Precision health research data points
19
Countries
Supported
Supported
1,982
Disease & Cancers
Supported
Supported
Precision Trial Program Delivery
Using data and digital health to translate programs and facilitating the clinical research delivery to accelerate research to overcome disease and cancer health disparities
01
Characterize big data sets along with patient trends.
02
Using precision intelligence, design and optimize clinical research to underserved communities using patient centric methodologies.
03
As lead CRO/complementary partner, we deploy our team and tools in communities to recruit, engage and conduct remote monitoring for patients while supplying data.
04
Prepare documentation packaging and submissions for sponsor, regulatory agencies, institutions while supporting future healthcare post market delivery integrations
Data Analytics
Intelligence/RWE
Ops/Strategy
Clinical Research Delivery
Research Aggregation/Care Delivery
Enable Programmatic Processes
to drive Patient Inclusivity within
the spectrum of clinical Research
Specialties
Uncovering the holistic picture to determine best paths of cancer and disease causes while developing targeted precision medicine strategies
Infectious Disease
Rare & Ultra Rare
Environmental
Oncology
Advancing Diversity In Clinical Development
An update on progress and results The call for achieving representative diversity in clinical trials and development programs is not new — and indeed dates back more than five decades in the United States — but has been amplified over the course of the COVID-19 pandemic as the realities of...
Clinical Trial ‘Next Generation’ Workforce Fuels Diversity Optimism
When Reginald Swift, founder, and CEO at Rubix Life Sciences, looks into the clinical trial crystal ball, he’s excited by how new technologies will help advance patient diversity. Still, he’s even more encouraged by the next generation of up-and-coming professionals. “I'm grateful for the younger generation because they're socially aware,”...
[Podcast] How health outcomes can be realized through patient product and service innovation
Our Founder & CEO, Reginald Swift, had the chance to sit in on the Life Science Success podcast with Donald David to discuss the mission of Rubix LS and what it means to achieve equitable health outcomes. The live discussion can be found here https://www.lifesciencesuccess.com/ReginaldSwift/ as well as the video...